Inicio › Cáncer de pulmón › Virginia

Ensayos clínicos de Cáncer de pulmón en Virginia

60 estudios sobre Cáncer de pulmón buscan participantes en Virginia.

Ciudades en Virginia

Texto oficial del estudio (inglés)

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Virginia Commonwealth University, Richmond

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07063745

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT06780098

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

University of Virginia Health System, Charlottesville
Virginia Commonwealth University (Vcu), Richmond

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07100080

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Hematology Oncology Associates of Fredericksburg Inc, Fredericksburg
Centra Alan B Pearson Regional Cancer Center, Lynchburg
Virginia Cancer Institute, Richmond
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Virginia Cancer Specialists, Fairfax

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07625644

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ballad Health Cancer Care - Bristol, Bristol
Augusta Health Center for Cancer and Blood Disorders, Fishersville
Centra Alan B Pearson Regional Cancer Center, Lynchburg
y 7 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

VCU Massey Cancer Center at Stony Point, Richmond
VCU Massey Comprehensive Cancer Center, Richmond
VCU Community Memorial Health Center, South Hill
y 1 más

ReclutandoFase 3

Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06096844

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

NEXT Virginia, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07458347

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

University of Virginia, Charlottesville
Virginia Cancer Specialists, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07020221

The Vanguard Study: Testing a New Way to Screen for Cancer

Sentara Martha Jefferson Hospital, Charlottesville
Inova Schar Cancer Institute, Fairfax
Inova Fair Oaks Hospital, Fairfax
y 5 más

ReclutandoSe aceptan voluntarios sanos

Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Virginia Oncology Associates, Norfolk

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Inova Schar Cancer Infusion Pharmacy, Fairfax
Inova Schar Cancer, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07519655

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Chesapeake Regional Medical Center, Chesapeake
Augusta Health Center for Cancer and Blood Disorders, Fishersville
Bon Secours Memorial Regional Medical Center, Mechanicsville
y 7 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

University of Virginia Cancer Center, Charlottesville

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Inova Schar Cancer Institute, Falls Church

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06400472

Distance-Based Exercise to Preserve Function and Prevent Disability

Bon Secours Memorial Regional Medical Center, Mechanicsville
Bon Secours Saint Francis Medical Center, Midlothian
Bon Secours Saint Mary's Hospital, Richmond

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07059884

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of Virginia Health System, Charlottesville
USO - Virginia Cancer Specialists, Fairfax
VCU Health Adult Outpatient Pavillion, Richmond

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

Inova Schar Cancer, Fairfax
Virginia Cancer Specialists, Fairfax
Virginia Cancer Institute, Richmond
y 2 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06712316

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

University of Virginia, Charlottesville
Virginia Cancer Specialists, Fairfax
Shenandoah Oncology, P.C., Winchester

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07185997

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

University of Virginia Cancer Center, Charlottesville
VCU Massey Comprehensive Cancer Center, Richmond

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT06287775

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

Virginia Cancer Specialists, Fairfax

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 oct 2026 · NCT05168566

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06835569

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

NEXT Oncology, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT06922591

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Fairfax

ReclutandoFase 2

Edades de 18 a 95 · Todos los sexos · Actualizado el 21 oct 2026 · NCT05061550

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

NEXT Virginia, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT06810544

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Virginia Cancer Specialists, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06244771

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

NEXT Oncology Virginia, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Fairfax

ReclutandoFase 1/2

Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07038343

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Virginia Cancer Specialists, Fairfax
Hematology Oncology Associates of Fredericksburg, Inc., Fredericksburg
Virginia Commonwealth University School of Medicine, Richmond
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06712355

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

NEXT Virginia, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT05786924

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Virginia Cancer Specialists, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06293898

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

Virginia Cancer Specialists - Arlington Office, Arlington
Virginia Cancer Specialists - Fairfax Office, Fairfax
Virginia Cancer Specialists - Bristow Office, Manassas
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07128199

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Kaiser Permanente Tysons Corner Medical Center, McLean
Kaiser Permanente-Caton Hill Medical Center, Woodbridge

ReclutandoFase 2

18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

University of Virginia Cancer Center, Charlottesville
Centra Alan B Pearson Regional Cancer Center, Lynchburg
Kaiser Permanente Tysons Corner Medical Center, McLean
y 5 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

UVA Comprehensive Cancer Center, Charlottesville
UVA Health Fontaine Research Park, Charlottesville
University of Virginia, Charlottesville
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07222566

Empathic Communication Skills (ECS) Training

Chesapeake Regional Healthcare (Data Collection Only), Chesapeake

ReclutandoSe aceptan voluntarios sanos

Edades de 18 a 100 · Todos los sexos · Actualizado el 7 oct 2026 · NCT05456841

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Virginia Cancer Specialists, Fairfax

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Virginia Cancer Specialists, Fairfax

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06765109

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Fairfax

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07127874

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.